United States Peptide Cancer Vaccine Market Report 2017

United States Peptide Cancer Vaccine Market Report 2017

1 Peptide Cancer Vaccine Overview

1.1 Product Overview and Scope of Peptide Cancer Vaccine

1.2 Classification of Peptide Cancer Vaccine by Product Category

1.2.1 United States Peptide Cancer Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Peptide Cancer Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Therapeutic CpG Peptide-Based Cancer Vaccine

1.2.4 Personalized Neoantigen Vaccination with Synthetic Long Peptides

1.2.5 Recombinant Peptide Vaccine

1.2.6 p53. Peptide-Pulsed Dendritic Cells Cancer Vaccines

1.2.7 Others

1.3 United States Peptide Cancer Vaccine Market by Application/End Users

1.3.1 United States Peptide Cancer Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Pancreatic Cancer

1.3.3 Gastric Cancer

1.3.4 Prostate Cancer

1.3.5 Breast Cancer

1.3.6 Others

1.4 United States Peptide Cancer Vaccine Market by Region

1.4.1 United States Peptide Cancer Vaccine Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Peptide Cancer Vaccine Status and Prospect (2012-2022)

1.4.3 Southwest Peptide Cancer Vaccine Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Peptide Cancer Vaccine Status and Prospect (2012-2022)

1.4.5 New England Peptide Cancer Vaccine Status and Prospect (2012-2022)

1.4.6 The South Peptide Cancer Vaccine Status and Prospect (2012-2022)

1.4.7 The Midwest Peptide Cancer Vaccine Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Peptide Cancer Vaccine (2012-2022)

1.5.1 United States Peptide Cancer Vaccine Sales and Growth Rate (2012-2022)

1.5.2 United States Peptide Cancer Vaccine Revenue and Growth Rate (2012-2022)

2 United States Peptide Cancer Vaccine Market Competition by Players/Suppliers

2.1 United States Peptide Cancer Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Peptide Cancer Vaccine Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Peptide Cancer Vaccine Average Price by Players/Suppliers (2012-2017)

2.4 United States Peptide Cancer Vaccine Market Competitive Situation and Trends

2.4.1 United States Peptide Cancer Vaccine Market Concentration Rate

2.4.2 United States Peptide Cancer Vaccine Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Peptide Cancer Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Peptide Cancer Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Peptide Cancer Vaccine Sales and Market Share by Region (2012-2017)

3.2 United States Peptide Cancer Vaccine Revenue and Market Share by Region (2012-2017)

3.3 United States Peptide Cancer Vaccine Price by Region (2012-2017)

4 United States Peptide Cancer Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Peptide Cancer Vaccine Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Peptide Cancer Vaccine Revenue and Market Share by Type (2012-2017)

4.3 United States Peptide Cancer Vaccine Price by Type (2012-2017)

4.4 United States Peptide Cancer Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Peptide Cancer Vaccine Sales (Volume) by Application (2012-2017)

5.1 United States Peptide Cancer Vaccine Sales and Market Share by Application (2012-2017)

5.2 United States Peptide Cancer Vaccine Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Peptide Cancer Vaccine Players/Suppliers Profiles and Sales Data

6.1 Enzo Life Science (Alexis Biotech)

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Antigen Express

6.2.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Antigen Express Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 BioLife Science

6.3.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 BioLife Science Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Immatics Biotechnologies

6.4.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Immatics Biotechnologies Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Immune Design

6.5.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Immune Design Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Imugene

6.6.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Imugene Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Immunomedics

6.7.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Immunomedics Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 ISA Pharmaceuticals

6.8.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Galena Biopharma

6.9.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Galena Biopharma Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Generex Biotechnology Corporation

6.10.2 Peptide Cancer Vaccine Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Generex Biotechnology Corporation Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Peptide Cancer Vaccine Manufacturing Cost Analysis

7.1 Peptide Cancer Vaccine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Peptide Cancer Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Peptide Cancer Vaccine Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Peptide Cancer Vaccine Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Peptide Cancer Vaccine Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Peptide Cancer Vaccine Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Peptide Cancer Vaccine Sales Volume Forecast by Type (2017-2022)

11.3 United States Peptide Cancer Vaccine Sales Volume Forecast by Application (2017-2022)

11.4 United States Peptide Cancer Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Peptide Cancer Vaccine

Figure United States Peptide Cancer Vaccine Market Size (K Pcs) by Type (2012-2022)

Figure United States Peptide Cancer Vaccine Sales Volume Market Share by Type (Product Category) in 2016

Figure Therapeutic CpG Peptide-Based Cancer Vaccine Product Picture

Figure Personalized Neoantigen Vaccination with Synthetic Long Peptides Product Picture

Figure Recombinant Peptide Vaccine Product Picture

Figure p53. Peptide-Pulsed Dendritic Cells Cancer Vaccines Product Picture

Figure Others Product Picture

Figure United States Peptide Cancer Vaccine Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Peptide Cancer Vaccine by Application in 2016

Figure Pancreatic Cancer Examples

Table Key Downstream Customer in Pancreatic Cancer

Figure Gastric Cancer Examples

Table Key Downstream Customer in Gastric Cancer

Figure Prostate Cancer Examples

Table Key Downstream Customer in Prostate Cancer

Figure Breast Cancer Examples

Table Key Downstream Customer in Breast Cancer

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Peptide Cancer Vaccine Market Size (Million USD) by Region (2012-2022)

Figure The West Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Peptide Cancer Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Peptide Cancer Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Peptide Cancer Vaccine Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Peptide Cancer Vaccine Sales Share by Players/Suppliers

Figure 2017 United States Peptide Cancer Vaccine Sales Share by Players/Suppliers

Figure United States Peptide Cancer Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Peptide Cancer Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Peptide Cancer Vaccine Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Peptide Cancer Vaccine Revenue Share by Players/Suppliers

Figure 2017 United States Peptide Cancer Vaccine Revenue Share by Players/Suppliers

Table United States Market Peptide Cancer Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Peptide Cancer Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Peptide Cancer Vaccine Market Share of Top 3 Players/Suppliers

Figure United States Peptide Cancer Vaccine Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Peptide Cancer Vaccine Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Peptide Cancer Vaccine Product Category

Table United States Peptide Cancer Vaccine Sales (K Pcs) by Region (2012-2017)

Table United States Peptide Cancer Vaccine Sales Share by Region (2012-2017)

Figure United States Peptide Cancer Vaccine Sales Share by Region (2012-2017)

Figure United States Peptide Cancer Vaccine Sales Market Share by Region in 2016

Table United States Peptide Cancer Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Peptide Cancer Vaccine Revenue Share by Region (2012-2017)

Figure United States Peptide Cancer Vaccine Revenue Market Share by Region (2012-2017)

Figure United States Peptide Cancer Vaccine Revenue Market Share by Region in 2016

Table United States Peptide Cancer Vaccine Price (USD/Pcs) by Region (2012-2017)

Table United States Peptide Cancer Vaccine Sales (K Pcs) by Type (2012-2017)

Table United States Peptide Cancer Vaccine Sales Share by Type (2012-2017)

Figure United States Peptide Cancer Vaccine Sales Share by Type (2012-2017)

Figure United States Peptide Cancer Vaccine Sales Market Share by Type in 2016

Table United States Peptide Cancer Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Peptide Cancer Vaccine Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Peptide Cancer Vaccine by Type (2012-2017)

Figure Revenue Market Share of Peptide Cancer Vaccine by Type in 2016

Table United States Peptide Cancer Vaccine Price (USD/Pcs) by Types (2012-2017)

Figure United States Peptide Cancer Vaccine Sales Growth Rate by Type (2012-2017)

Table United States Peptide Cancer Vaccine Sales (K Pcs) by Application (2012-2017)

Table United States Peptide Cancer Vaccine Sales Market Share by Application (2012-2017)

Figure United States Peptide Cancer Vaccine Sales Market Share by Application (2012-2017)

Figure United States Peptide Cancer Vaccine Sales Market Share by Application in 2016

Table United States Peptide Cancer Vaccine Sales Growth Rate by Application (2012-2017)

Figure United States Peptide Cancer Vaccine Sales Growth Rate by Application (2012-2017)

Table Enzo Life Science (Alexis Biotech) Basic Information List

Table Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table Antigen Express Basic Information List

Table Antigen Express Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Antigen Express Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure Antigen Express Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure Antigen Express Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table BioLife Science Basic Information List

Table BioLife Science Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure BioLife Science Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure BioLife Science Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure BioLife Science Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table Immatics Biotechnologies Basic Information List

Table Immatics Biotechnologies Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Immatics Biotechnologies Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure Immatics Biotechnologies Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure Immatics Biotechnologies Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table Immune Design Basic Information List

Table Immune Design Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Immune Design Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure Immune Design Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure Immune Design Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table Imugene Basic Information List

Table Imugene Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Imugene Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure Imugene Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure Imugene Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table Immunomedics Basic Information List

Table Immunomedics Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Immunomedics Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure Immunomedics Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure Immunomedics Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table ISA Pharmaceuticals Basic Information List

Table ISA Pharmaceuticals Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure ISA Pharmaceuticals Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure ISA Pharmaceuticals Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure ISA Pharmaceuticals Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table Galena Biopharma Basic Information List

Table Galena Biopharma Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Galena Biopharma Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure Galena Biopharma Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure Galena Biopharma Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table Generex Biotechnology Corporation Basic Information List

Table Generex Biotechnology Corporation Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Generex Biotechnology Corporation Peptide Cancer Vaccine Sales Growth Rate (2012-2017)

Figure Generex Biotechnology Corporation Peptide Cancer Vaccine Sales Market Share in United States (2012-2017)

Figure Generex Biotechnology Corporation Peptide Cancer Vaccine Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Peptide Cancer Vaccine

Figure Manufacturing Process Analysis of Peptide Cancer Vaccine

Figure Peptide Cancer Vaccine Industrial Chain Analysis

Table Raw Materials Sources of Peptide Cancer Vaccine Major Players/Suppliers in 2016

Table Major Buyers of Peptide Cancer Vaccine

Table Distributors/Traders List

Figure United States Peptide Cancer Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Peptide Cancer Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Peptide Cancer Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Peptide Cancer Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Peptide Cancer Vaccine Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Peptide Cancer Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Peptide Cancer Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Peptide Cancer Vaccine Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Peptide Cancer Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Peptide Cancer Vaccine Sales Volume Share Forecast by Region (2017-2022)

Figure United States Peptide Cancer Vaccine Sales Volume Share Forecast by Region (2017-2022)

Figure United States Peptide Cancer Vaccine Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources